X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (463) 463
Publication (80) 80
Book / eBook (9) 9
Book Chapter (6) 6
Book Review (3) 3
Newspaper Article (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (198) 198
female (179) 179
oncology (170) 170
index medicus (168) 168
breast cancer (148) 148
middle aged (114) 114
adult (101) 101
aged (78) 78
cancer (78) 78
breast neoplasms - genetics (77) 77
breast neoplasms - pathology (68) 68
risk factors (65) 65
mutation (63) 63
article (58) 58
risk (46) 46
medicin och hälsovetenskap (45) 45
research (45) 45
women (45) 45
medical and health sciences (44) 44
genetic predisposition to disease (41) 41
genetic aspects (38) 38
ovarian cancer (38) 38
skin and connective tissue diseases (37) 37
genes, brca2 (36) 36
analysis (35) 35
breast neoplasms - drug therapy (35) 35
chemotherapy (34) 34
genes, brca1 (34) 34
health aspects (33) 33
medicine & public health (32) 32
breast neoplasms - metabolism (31) 31
clinical medicine (31) 31
diagnosis (31) 31
klinisk medicin (31) 31
cancer och onkologi (30) 30
prognosis (30) 30
cancer and oncology (29) 29
male (29) 29
ovarian-cancer (28) 28
retrospective studies (27) 27
care and treatment (26) 26
ovarian neoplasms - genetics (26) 26
survival (26) 26
brca1 (25) 25
brca1 protein - genetics (25) 25
genetics (25) 25
breast neoplasms - prevention & control (24) 24
medical genetics (24) 24
risk assessment (24) 24
treatment outcome (24) 24
aged, 80 and over (23) 23
brca2 protein - genetics (23) 23
breast (23) 23
epidemiology (23) 23
neoplasm staging (23) 23
endocrine system diseases (22) 22
young adult (22) 22
brca2 (21) 21
breast neoplasms - diagnosis (21) 21
breast neoplasms - surgery (21) 21
abridged index medicus (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
breast-cancer (19) 19
genes (19) 19
genetic testing (19) 19
heterozygote (19) 19
medicinsk genetik (19) 19
medicinska och farmaceutiska grundvetenskaper (19) 19
tamoxifen (19) 19
basic medicine (18) 18
breast neoplasms - epidemiology (18) 18
breast neoplasms - mortality (18) 18
metastasis (18) 18
animals (17) 17
gene mutations (17) 17
prevention (17) 17
brca mutations (16) 16
expression (16) 16
genetic screening (16) 16
surgical adjuvant breast (16) 16
breast neoplasms - therapy (15) 15
carcinoma (15) 15
disease-free survival (15) 15
postmenopausal women (15) 15
brca (14) 14
carriers (14) 14
genome-wide association (14) 14
genotype (14) 14
mutations (14) 14
tumors (14) 14
antineoplastic agents - therapeutic use (13) 13
brca2 mutation carriers (13) 13
cancer patients (13) 13
follow-up studies (13) 13
gene (13) 13
mastectomy (13) 13
obstetrics & gynecology (13) 13
oncology, experimental (13) 13
polymorphism, single nucleotide (13) 13
prevalence (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9737, pp. 235 - 244
Journal Article
Seminars in Oncology, ISSN 0093-7754, 04/2004, Volume 31, Issue 7, pp. 22 - 29
Several studies have suggested that cyclooxygenase-2 (COX-2) expression is associated with parameters of aggressive breast cancer, including large tumor size,... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and... 
Hematology, Oncology and Palliative Medicine | ZOLEDRONIC ACID | SURGICAL ADJUVANT BREAST | ONCOLOGY | STATIN USE | LOW-DOSE TAMOXIFEN | RANDOMIZED-TRIAL | FOLLOW-UP | RISK | BOWEL PROJECT | POSTMENOPAUSAL WOMEN | GENOME-WIDE ASSOCIATION | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer
Journal Article
Journal of Alloys and Compounds, ISSN 0925-8388, 12/2016, Volume 687, pp. 402 - 412
Journal Article
by Couch, Fergus J and Wang, Xianshu and McGuffog, Lesley and Lee, Anew and Olswold, Curtis and Kuchenbaecker, Karoline B and Soucy, Penny and Fredericksen, Zachary and Barrowdale, Daniel and Dennis, Joe and Gaudet, Mia M and Dicks, Ed and Kosel, Matthew and Healey, Sue and Sinilnikova, Olga M and Lee, Adam and Bacot, François and Vincent, Daniel and Hogervorst, Frans B. L and Peock, Susan and Stoppa-Lyonnet, Dominique and Jakubowska, Anna and Radice, Paolo and Schmutzler, Rita Katharina and Domchek, Susan M and Piedmonte, Marion and Singer, Christian F and Friedman, Eitan and Thomassen, Mads and Hansen, Thomas V. O and Neuhausen, Susan L and Szabo, Csilla I and Blanco, Ignacio and Greene, Mark H and Karlan, Beth Y and Garber, Judy and Phelan, Catherine M and Weitzel, Jeffrey N and Montagna, Marco and Olah, Edith and Anulis, Irene L and Godwin, Anew K and Yannoukakos, koulis and Goldgar, David E and Caldes, Trinidad and Nevanlinna, Heli and Osorio, Ana and Terry, Mary Beth and Daly, Mary B and van Rensburg, Elizabeth J and Hamann, Ute and Ramus, Susan J and Toland, Amanda Ewart and Caligo, Maria A and Olopade, Olufunmilayo I and Tung, Nadine and Claes, Kathleen and Beattie, Mary S and Southey, Melissa C and Imyanitov, Evgeny N and Tischkowitz, Marc and Janavicius, Ramunas and John, Esther M and Kwong, Ava and Diez, Orland and Balmaña, Judith and Barkardottir, Rosa B and Arun, Banu K and Rennert, Gad and teo, Soo-Hwang and Ganz, Patricia A and Campbell, Ian and van der Hout, Annemarie H and van Deurzen, Carolien H. M and Seynaeve, Caroline and Gómez Garcia, Encarna B and van Leeuwen, Flora E and Meijers-Heijboer, Hanne E. J and Gille, Johannes J. P and Ausems, Margreet G. E. M and Blok, Marinus J and Ligtenberg, Marjolijn J. L and Rookus, Matti A and Devilee, Peter and Verhoef, Senno and van Os, Theo A. M and Wijnen, Juul T and Frost, Debra and Ellis, Steve and Fineberg, Elena and Platte, Radka and Evans, D. Gareth and Izatt, Louise and Eeles, Rosalind A and Adlard, Julian and Eccles, Diana M and Cook, Jackie and Brewer, Carole and Douglas, Fiona and Hodgson, Shirley and ... and KConFab Investigators and Ontario Canc Genetics Network and EMBRACE and GEMO Study Collaborators and CIMBA and HEBON and BCFR and SWE-BRCA and Ontario Cancer Genetics Network and kConFab Investigators and on behalf of CIMBA and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologi and Hälsouniversitetet
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 14, pp. 3711 - 3720
Purpose: To explore whether a cross-talk exists between PARP inhibition and PD-L1/PD-1 immune checkpoint axis, and determine whether blockade of PD-L1/PD-1... 
CELL LUNG-CANCER | BREAST-CANCER | OVEREXPRESSION | ACTIVATION | THERAPY | PEMBROLIZUMAB | ONCOLOGY | OVARIAN-CANCER | PROVIDES | COMBINATION | CHEMOTHERAPY | Tumor Microenvironment - drug effects | Poly (ADP-Ribose) Polymerase-1 - immunology | Breast Neoplasms - immunology | Humans | Poly(ADP-ribose) Polymerase Inhibitors - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Breast Neoplasms - drug therapy | Poly (ADP-Ribose) Polymerase-1 - antagonists & inhibitors | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Tumor Microenvironment - immunology | Xenograft Model Antitumor Assays | Immunosuppression | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell Line, Tumor | Female | Mice | Gene Expression Regulation, Neoplastic - drug effects | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Lymphocytes, Tumor-Infiltrating - immunology | Cell culture | Flow cytometry | Biotechnology | Animal models | PD-1 protein | Immunoblotting | Lymphocytes T | Immunity | Anticancer properties | Lymphocytes | Xenografts | Tumor-infiltrating lymphocytes | Tumor cells | Poly(ADP-ribose) polymerase | Breast cancer | Tumor cell lines | Inhibitors | Immune checkpoint | Experimental design | PD-L1 protein | Cell lines | Breast | In vivo methods and tests | Tumors | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2008, Volume 26, Issue 26, pp. 4282 - 4288
Purpose Mutations in the BRCA1 and BRCA2 genes confer greater risk of developing breast cancer. We determined whether tumor pathologic features and clinical... 
WOMEN | MOLECULAR PORTRAITS | HEREDITARY | ONCOLOGY | GENES | PHENOTYPE | OVARIAN-CANCER | MUTATIONS | CARCINOMA | TUMORS | FEATURES | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Humans | Genes, BRCA2 | Female | Breast Neoplasms - diagnosis | Retrospective Studies | Genes, BRCA1 | Mutation | Breast Cancer
Journal Article
Current Breast Cancer Reports, ISSN 1943-4588, 9/2019, Volume 11, Issue 3, pp. 117 - 122
Breast cancer is a complex disease that is fueled by genetic as well as non-genetic factors. As data risk estimates become better, stratifying a woman’s risk... 
Polygenic risk score | Medicine & Public Health | Risk models | Oncology | Internal Medicine | Breast cancer | Single nucleotide polymorphism | Genetic testing | Surgical Oncology | Tyrer-Cuzick | Prevention | Oncology, Experimental | Genomics | Genetic aspects | Single nucleotide polymorphisms | Research | Health aspects | Biopolymers | Risk factors | Genetic screening | Cancer
Journal Article
Journal Article
by Rebbeck, Timothy R and Friebel, Tara M and Friedman, Eitan and Hamann, Ute and Huo, Dezheng and Kwong, Ava and Olah, Edith and Olopade, Olufunmilayo I and Solano, Angela R and Teo, Soo‐Hwang and Thomassen, Mads and Weitzel, Jeffrey N and Chan, TL and Couch, Fergus J and Goldgar, David E and Kruse, Torben A and Palmero, Edenir Inêz and Park, Sue Kyung and Torres, Diana and Rensburg, Elizabeth J and McGuffog, Lesley and Parsons, Michael T and Leslie, Goska and Aalfs, Cora M and Abugattas, Julio and Adlard, Julian and Agata, Simona and Aittomäki, Kristiina and Andrews, Lesley and Andrulis, Irene L and Arason, Adalgeir and Arnold, Norbert and Arun, Banu K and Asseryanis, Ella and Auerbach, Leo and Azzollini, Jacopo and Balmaña, Judith and Barile, Monica and Barkardottir, Rosa B and Barrowdale, Daniel and Benitez, Javier and Berger, Andreas and Berger, Raanan and Blanco, Amie M and Blazer, Kathleen R and Blok, Marinus J and Bonadona, Valérie and Bonanni, Bernardo and Bradbury, Angela R and Brewer, Carole and Buecher, Bruno and Buys, Saundra S and Caldes, Trinidad and Caliebe, Almuth and Caligo, Maria A and Campbell, Ian and Caputo, Sandrine M and Chiquette, Jocelyne and Chung, Wendy K and Claes, Kathleen B.M and Collée, J. Margriet and Cook, Jackie and Davidson, Rosemarie and la Hoya, Miguel and Leeneer, Kim and Pauw, Antoine and Delnatte, Capucine and Diez, Orland and Ding, Yuan Chun and Ditsch, Nina and Domchek, Susan M and Dorfling, Cecilia M and Velazquez, Carolina and Dworniczak, Bernd and Eason, Jacqueline and Easton, Douglas F and Eeles, Ros and Ehrencrona, Hans and Ejlertsen, Bent and Engel, Christoph and Engert, Stefanie and Evans, D. Gareth and Faivre, Laurence and Feliubadaló, Lidia and Ferrer, Sandra Fert and Foretova, Lenka and Fowler, Jeffrey and Frost, Debra and Galvão, Henrique C. R and Ganz, Patricia A and Garber, Judy and Gauthier‐Villars, Marion and Gehrig, Andrea and Gerdes, Anne‐Marie and Gesta, Paul and Giannini, Giuseppe and Giraud, Sophie and Glendon, Gord and Godwin, Andrew K and Greene, Mark H and ... and KConFab Investigators and HEBON and EMBRACE and GEMO Study Collaborators
Human Mutation, ISSN 1059-7794, 05/2018, Volume 39, Issue 5, pp. 593 - 620
Journal Article